Peptide deformylase inhibitors

Details for Australian Patent Application No. 2008323998 (hide)

Owner GlaxoSmithKline LLC

Inventors Aubart, Kelly M.; Norton, Beth; Dreabit, Jason Christopher; Lee, Jinhwa; Benowitz, Andrew B.; Qin, Donghui; Christensen IV., Siegfried Benjamin; Liao, Xiangmin; Fang, Yuhong; Knox, Andrew Nicholson

Agent Davies Collison Cave

Pub. Number AU-A-2008323998

PCT Pub. Number WO2009/061879

Priority 60/986,631 09.11.07 US

Filing date 6 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/195 (2006.01)

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061879 Priority application(s): WO2009/061879

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324002-System and method for synchronizing medication configuration information among systems containing medication configuration information

2008323996-Financial transaction funds collection and distribution